FIRST MANHATTAN CO. LLC. BioCryst Pharmaceuticals, Inc. Transaction History

FIRST MANHATTAN CO. LLC. portfolio value:

$22.74M
portfolio value

FIRST MANHATTAN CO. LLC. quarter portfolio value change:

+19.09%
quarter

BioCryst Pharmaceuticals, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share 0.00% 0 shares 3.64M $12.6 1.80M
Q2 2022 share Increase 0.00% 1.80M shares 19.09M $10.58 1.80M